SCHEMBL7862852

SCHEMBL7862852

CCCCCC(=O)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(OC(=O)NCCOC)nc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.47
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
AKT1 P31749 4/20 0.43
GAA P10253 1/20 0.40
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7862831 0.94 PKM (0.41) PTPN1CA1CA2MAPTALDH1A1
SCHEMBL7862667 0.92 PTPN1 (0.47) PTPN1CA1CA2SMN1; SMN2MAPT
SCHEMBL7869445 0.90 PKM (0.43) CA1CA2ALDH1A1MEN1KMT2A
SCHEMBL7862672 0.89 L3MBTL1 (0.47) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL9018165 0.88 PTPN1 (0.51) PTPN1CA1CA2SMN1; SMN2MAPT
SCHEMBL9574752 0.87 L3MBTL1 (0.53) ALDH1A1MEN1KMT2APKM
SCHEMBL8869428 0.87 PTPN1 (0.49) PTPN1CA1CA2SMN1; SMN2MAPT
SCHEMBL7862740 0.87 ALDH1A1 (0.48) CA1CA2SMN1; SMN2MAPTALDH1A1
SCHEMBL7869400 0.86 CA12 (0.42) PTPN1CA1CA2SMN1; SMN2MAPT
SCHEMBL7862801 0.86 CA2 (0.48) CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed